ClinicalTrials.Veeva

Menu

Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure

H

Harbin Medical University

Status

Unknown

Conditions

Chronic Heart Failure

Treatments

Drug: HTEA

Study type

Observational

Funder types

Other

Identifiers

NCT02292030
dong hao

Details and patient eligibility

About

The purpose of this study is to explore the efficacy of low energy cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.

Full description

The purpose of this study is to explore the efficacy of low energy (30J) cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.

Enrollment

60 estimated patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • congestive heart failure accompanied by atrial fibrillation.

Exclusion criteria

  • Valvular heart diseases.

Trial design

60 participants in 2 patient groups

cardioversion+HTEA
Description:
Heart failure patients accompanied by atrial fibrillation receive the treatment of cardioversion+HTEA.
Treatment:
Drug: HTEA
only cardioversion
Description:
Heart failure patients accompanied by atrial fibrillation receive the treatment of cardioversion, but not with HTEA.
Treatment:
Drug: HTEA

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems